Patients who are non-Hispanic Black, possess public insurance, and have lower markers of childhood opportunity were more likely to be seen first for a concussion in the emergency department, potentially impacting follow-up care

Researchers at Children’s Hospital of Philadelphia (CHOP) found that emicizumab, a widely used drug for hemophilia A, could also improve blood clotting for select people with hemophilia B depending on their genes. The preclinical study, recently published in Blood, offers proof that this class of hemophilia A drug could potentially be used to treat hemophilia B.

CHOP announced the opening of a 5,077 square foot new Sleep Lab at its new Specialty Care Center in Newtown Square, PA.

The rapid rise of youth sports has led to increased prevalence of repeat knee-related injuries among children and adolescents, notably those ages 10- to 17. In fact, patellar (kneecap) instability is one of the most common causes of physical trauma in this age group – six times higher than adults. Currently, most clinicians rely on advanced imaging to guide their treatment approach, which can be costly and is not usually available in a clinic. However, researchers at Children’s Hospital of Philadelphia, revealed that ultrasound technology offers a transformative solution since it’s inexpensive and portable, compared to MRI and CT scans, and clinicians can track knee injuries and their response to treatment over time within a clinic.

Find out about a new four-part pediatric vaccination video series, vaccine discussion guides, and an interactive platform for reviewing global vaccine use and impact.

A group of experts on the frontlines during the COVID-19 pandemic share their experiences and findings to help improve our collective effort during any future similar event that might occur. See what they observed.

See how the use of standing orders can help guide clinicians through complicated vaccination recommendations.

Recent data highlights a worrisome trend in childhood vaccination rates. Check out the findings.

Review the science behind measuring hepatitis B antibody titers and find tips for communicating with patients about the importance of this testing and the process.

Using state-of-the-art technology, researchers say understanding underlying movements and mechanisms may pave the way for more effective forms of CRISPR-based therapy.